Business Description
ALTEOGEN Inc. is a South Korean biotechnology company founded in 2008 and based in Daejeon, focused on creating improved versions of existing biological medicines, cancer-targeting drug combinations, and biosimilar treatments. The company is advancing several clinical programs, including therapies for breast cancer, gastric cancer, ovarian cancer, and hemophilia, using its proprietary drug development technologies. ALTEOGEN also holds partnerships with Kissei Pharmaceutical, Cristalia, and Biogen to expand the reach of its treatments across global markets.
